Sat, May 24, 2025
[Archive]
Volume 16, Issue 3 (September 2024 2024)
Iranian Journal of Blood and Cancer 2024, 16(3): 1-7 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Behzadi A, Poormehr P, Farahbakhsh N. Mesenteric Vein Thrombosis (MVT) as the Cause of Abdominal Pain in Pediatric Cystic Fibrosis (CF): A Case Report. Iranian Journal of Blood and Cancer 2024; 16 (3) :1-7
URL: http://ijbc.ir/article-1-1617-en.html
URL: http://ijbc.ir/article-1-1617-en.html
1- School of medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Department of Pediatric Pulmonology, Mofid Pediatrics Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ,naznin26farabakhsh@gmail.com
2- Department of Pediatric Pulmonology, Mofid Pediatrics Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ,
Abstract: (22831 Views)
Background: Cystic fibrosis (CF) represents a prevalent autosomal recessive condition that predominantly impacts the respiratory and gastrointestinal systems. Abdominal pain in patients with cystic fibrosis is commonly linked to conditions including distal intestinal obstruction syndrome, pancreatitis, or hepatic disease. This case report presents a rare etiology of abdominal pain, specifically mesenteric vein thrombosis (MVT) attributed to hereditary thrombophilia, observed in a pediatric patient diagnosed with cystic fibrosis (CF).
Case Presentation: A 3-year-old female patient with a confirmed diagnosis of cystic fibrosis, established through a sweat chloride test, exhibited significant right lower quadrant (RLQ) abdominal pain. The initial diagnostic evaluation, comprising an abdominal series, laboratory assessments, and abdominal ultrasound, ruled out prevalent etiologies including DIOS, pancreatitis, and appendicitis. The presence of persistent pain necessitated additional diagnostic evaluation through a contrast-enhanced CT scan, which subsequently identified mesenteric vein thrombosis. The analysis of genetic testing revealed a homozygous mutation in the MTHFR C677T gene, which is suggestive of hereditary thrombophilia. These findings were corroborated through Sanger sequencing methodologies.
Conclusion: This case highlights the importance of evaluating uncommon conditions such as mesenteric vein thrombosis in pediatric patients with cystic fibrosis who exhibit atypical abdominal pain. An extensive diagnostic strategy, incorporating genetic analysis, is crucial for the prompt identification and focused intervention necessary to avert significant complications. Abdominal pain is a significant clinical symptom that may be associated with various underlying conditions, including cystic fibrosis, venous thrombosis, and mesenteric ischemia. Each of these conditions presents unique challenges in diagnosis and management, necessitating a comprehensive understanding of their pathophysiology and clinical implications.
Case Presentation: A 3-year-old female patient with a confirmed diagnosis of cystic fibrosis, established through a sweat chloride test, exhibited significant right lower quadrant (RLQ) abdominal pain. The initial diagnostic evaluation, comprising an abdominal series, laboratory assessments, and abdominal ultrasound, ruled out prevalent etiologies including DIOS, pancreatitis, and appendicitis. The presence of persistent pain necessitated additional diagnostic evaluation through a contrast-enhanced CT scan, which subsequently identified mesenteric vein thrombosis. The analysis of genetic testing revealed a homozygous mutation in the MTHFR C677T gene, which is suggestive of hereditary thrombophilia. These findings were corroborated through Sanger sequencing methodologies.
Conclusion: This case highlights the importance of evaluating uncommon conditions such as mesenteric vein thrombosis in pediatric patients with cystic fibrosis who exhibit atypical abdominal pain. An extensive diagnostic strategy, incorporating genetic analysis, is crucial for the prompt identification and focused intervention necessary to avert significant complications. Abdominal pain is a significant clinical symptom that may be associated with various underlying conditions, including cystic fibrosis, venous thrombosis, and mesenteric ischemia. Each of these conditions presents unique challenges in diagnosis and management, necessitating a comprehensive understanding of their pathophysiology and clinical implications.
: Case report |
Subject:
Pediatric Hematology & Oncology
Received: 2024/07/31 | Accepted: 2024/09/23 | Published: 2024/09/30
Received: 2024/07/31 | Accepted: 2024/09/23 | Published: 2024/09/30
References
1. Branfield S, Washington AV. Control the platelets, control the disease: A novel cystic fibrosis hypothesis. J Thromb Haemost. 2020 Jul;18(7):1531-4. [DOI:10.1111/jth.14868]
2. Döring G, Elborn JS, Johannesson M, de Jonge H, Griese M, Smyth A, et al. Clinical trials in cystic fibrosis. In: Journal of Cystic Fibrosis. 2007. p. 85-99. [DOI:10.1016/j.jcf.2007.02.001]
3. Knight-Perry J, Branchford BR, Thornhill D, Martiniano SL, Sagel SD, Wang M. Venous thromboembolism in children with cystic fibrosis: Retrospective incidence and intrapopulation risk factors. Thromb Res [Serial online]. 2017 Oct;158(May):161-6 (6 screens). Available from: http://dx.doi.org/10.1016/j.thromres.2017.08.022 [DOI:10.1016/j.thromres.2017.08.022]
4. Mingora CM, Flume PA. Pulmonary Complications in Cystic Fibrosis: Past, Present, and Future: Adult Cystic Fibrosis Series. Chest [Serial online]. 2021 Oct 1;160(4):1232-40 (9 screens). Available from: https://pubmed.ncbi.nlm.nih.gov/34147501/ [DOI:10.1016/j.chest.2021.06.017]
5. Konrad J, Eber E, Stadlbauer V. Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators. Paediatr Respir Rev [Serial online]. 2022 Jun 1;42:9-16 (8 screens). Available from: https://pubmed.ncbi.nlm.nih.gov/33485777/ [DOI:10.1016/j.prrv.2020.12.001]
6. Scott JA, Barry PJ, Jones AM, Athwal VS. Management of superior mesenteric venous thrombus in cystic fibrosis related liver disease. Paediatr Respir Rev [serial online]. 2020 Sep;35:106-108 (3 screens). Available from : 10.1016/j.prrv.2020.04.007. Epub 2020 Apr 21. [DOI:10.1016/j.prrv.2020.04.007]
7. Mavilia M. Distal intestinal obstructive syndrome (DIOS): a gastrointestinal complication of cystic fibrosis in adults. Clin J Gastroenterol [serial online]. 2019;12(6):571-573 (3 screens).Available from : 10.1007/s12328-019-00979-7. [DOI:10.1007/s12328-019-00979-7]
8. Gillespie CD, O'Reilly MK, Allen GN, McDermott S, Chan VO, Ridge CA. Imaging the Abdominal Manifestations of Cystic Fibrosis. Int J Hepatol [serial online]. 2017;2017:1-9 (9 screens). Available from : 10.1155/2017/5128760 [DOI:10.1155/2017/5128760]
9. Lusman SS, Grand R. Approach to chronic abdominal pain in Cystic Fibrosis. J Cyst Fibros [serial online]. 2017 Nov;16 Suppl 2:S24-S31 (8 screens). Available from: https://linkinghub.elsevier.com/retrieve/pii/S1569199317308111 [DOI:10.1016/j.jcf.2017.06.009]
10. Dracea LL, Vida LC, Patran OC. Appendicitis in Cystic Fibrosis: A Challenging Diagnosis. Bulletin of the Transilvania University of Brasov [serial online]. 2020 Dec 30;13 (62)(2):19-26 (7 screens). Available from : http://webbut.unitbv.ro/index.php/Series_VI/article/view/535 [DOI:10.31926/but.ms.2020.62.13.2.3]
11. Lindberg U, Svensson L, Hellmark T, Segelmark M, Shannon O. Increased platelet activation occurs in cystic fibrosis patients and correlates to clinical status. Thromb Res [serial online]. 2018 Feb;162(November 2017):32-7 (6 screens). Available from: [DOI:10.1016/j.thromres.2017.12.012]
12. Roesch EA, Nichols DP, Chmiel JF. Inflammation in cystic fibrosis: An update. Pediatr Pulmonol [serial online]. 2018;53(S3):S30-S50 (21 screens). Available from : 10.1002/ppul.24129 [DOI:10.1002/ppul.24129]
13. Samoyedny A, Sajja S, Ratnasekera A. Idiopathic acute mesenteric venous thrombosis causing ischemic enteritis: A case report. Int J Surg Case Rep [serial online]. 2020;74:247-250 (4 screens). Available from : 10.1016/j.ijscr.2020.08.030 [DOI:10.1016/j.ijscr.2020.08.030]
14. Arora K, Naren AP. Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function. Curr Drug Targets. 2016;17(11):1275-81. [DOI:10.2174/1389450117666151209114343]
15. Spicuzza L, Sciuto C, Di Dio L, Mattina T, Leonardi S, del Giudice MM, et al. Mild cystic fibrosis in patients with the rare P5L CFTR mutation. J Cyst Fibros. 2012 Jan;11(1):30-3. [DOI:10.1016/j.jcf.2011.08.009]
16. Handschick M, Hedtfeld S, Tümmler B. Frequency of the hyperactive W493R ENaC variant in carriers of a CFTR mutation. J Cyst Fibros. 2012 Jan;11(1):53-5. [DOI:10.1016/j.jcf.2011.08.008]
17. Freswick PN, Reid EK, Mascarenhas MR. Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis. Nutrients. 2022 Mar 23;14(7):1341. [DOI:10.3390/nu14071341]
18. Anıl H, Kılıç Yıldırım G, Harmancı K, Bozkurt Turhan A, Akay OM, Bör Ö, et al. Thromboelastogram as a Tool to Predict Hypercoagulability in Children With Cystic Fibrosis. Clin Appl Thromb. 2018 Mar;24(2):348-52. [DOI:10.1177/1076029616683045]
19. McGivern TJ, Molloy K, Bahar M, McElvaney NG, Moran N, Kerrigan SW. A platelet dense-granule secretion defect may lead to a muted inflammatory cell mobilization response in cystic fibrosis patients. J Thromb Haemost [serial online]. 2013;11(10):1939-1942 (4 screens). Available from : 10.1111/jth.12377 [DOI:10.1111/jth.12377]
20. Marteyn BS, Burgel P-R, Meijer L, Witko-Sarsat V. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic Fibrosis. Front Cell Infect Microbiol. 2017;7:243. [DOI:10.3389/fcimb.2017.00243]
21. Rimessi A, Bezzerri V, Patergnani S, Marchi S, Cabrini G, Pinton P. Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis. Nat Commun [serial online]. 2015;6:6201 (16 screens). Published 2015 Feb 4. Available from : 10.1038/ncomms7201 [DOI:10.1038/ncomms7201]
22. Branchford BR, Carpenter SL. The Role of Inflammation in Venous Thromboembolism. Front Pediatr. 2018;6:142. [DOI:10.3389/fped.2018.00142]
23. Balfour-Lynn IM, Malbon K, Burman JF, Davidson SJ. Thrombophilia in children with cystic fibrosis. Pediatr Pulmonol. 2005;39. [DOI:10.1002/ppul.20181]
24. Williams V, Griffiths ABM, Sci BM, Yap ZL, Martin J, Smith G, et al. Increased Thrombophilic Tendency in Pediatric Cystic Fibrosis Patients. :71-6. [DOI:10.1177/1076029609334627]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
- Iranian Journal of Blood and Cancer
- Journal Tel: +989369936116
- Publisher Tel: +982122275917
- Mail: Info@ijbc.ir
